1
Step 1
Quick pre-screening call with our patient engagement team to check which studies are suitable.
Register for more information and find out how you could not only make a difference in the future of healthcare discovery, but benefit from our state-of-the-art assessments,
"*" indicates required fields
Explore the page
Re:Cognition Health has recently been featured on BBC One’s Panorama, “Alzheimer’s: A Turning Point?”. This follows the journey of volunteers participating in clinical trials, some from Re:Cognition Health’s UK centres, testing new-generation medications designed to slow down the progression of the disease. For those in the UK, you can still watch this on BBC iPlayer.
Clinical trials are essential for advancing our understanding of medicine and improving the healthcare and quality of life for everyone affected by dementia and cognitive impairment. In 2023 nearly a million people participated in health and social care research in the UK, according to the National Institute for Health and Care Research (NIHR)
This is a very exciting time for research, with every study conducted we understand more about specific diseases and conditions, getting closer to finding new treatments and ultimately a cure.
Our clinics located throughout the UK are set up for your comfort with experts and consultants to walk you through the trial process.
The Re:Cognition Health UK and US site networks are proud to be preferred sites within the PPD Select Partnership Program of Thermo Fisher Scientific’s PPD clinical research business, a global leader in clinical research.
We’re excited about the opportunities this relationship brings, and we are looking forward to working with the PPD Strategic Site Collaborations team and evolving our relationship within the PPD Select Program, across our existing ten sites.
Explore our blogs, news, and resources as you prepare for the trials.
Sign Up for Our Newsletter
Get our latest news, insights, and expert knowledge
"*" indicates required fields